No Detail Found!

Simvastatin and dexamethasone potentiate antitumor activity of fotemustine.

Author(s)
Mahir Kula Department of Medical Pharmacology, Istanbul University, Turkey
Gamze Tanriverdi Department of Histology and Embryology, Faculty of Cerrahpasa Medical, Istanbul University, Turkey
Ersoy Oksuz Department of Medical Pharmacology, Istanbul University, Turkey
Ayhan Bilir Department of Histology and Embryology, Faculty of Istanbul Medical, Istanbul University, Turkey
Andleeb Shahzadi Department of Medical Pharmacology, Istanbul University, Turkey
Zeliha Yazici Department of Medical Pharmacology, Istanbul University, Turkey
Abstract
The present study was designed to investigate the combined effect of fotemustine, e, a nitrosureas antineoplastic agent along with simvastarin and/or dexamethasone on C6 glioblastoma. The C6 glioblastoma cells (1 X106) were inoculated in rat brains. Ten days later, rats were treated with 10 mg kg-1 fotemustine, 3 mg kg-1 day-1 dexamethasone and 3 mg kg-1 day-1 simvastarin alone or with their combination. Monoclonal antibody Ki-67 was used to evaluate cell proliferation. The effects of these drug alone or in combination on fatty acid profile of C6 glioblastoma were determined using capillary gas chromatography. Dexamethasone±simvastatin decreased the tumor weight 36-46% (p = 0.001-0.029). The fotemustine+dexamethasone+simvastatin combination was more effective than the drugs given separately in inhibiting the growth of the tumor (33.9-58.5%, p = 0.000). In the fotemustine+dexamethasone+simvastatin group, the total fatty acid amount was high compared with control tumors, whereas low in the fotemustine+simvastatin group (31.95±1.91 and 16.11±1.96 jug mg-1, p = 0.021). The number of Ki-67 positive cell decreased compared with control tumors by drug therapy except dexamethasone alone. The decrease was greatest in the treatment with fotemustm. i e+dexamethasone+sm vastatin (26.5-51.8%, p = 0.000-0.020). These data show that, fotemustine+dexamethasone+simvastatin combination is more effective than fotemustine alone on inhibition of cell proliferation and tumor progression.
Publication Details
Page(s) 267-274
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 10, Issue: 5, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

28

Views